System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Roberto Barriales-Villa

Cardiology — Complexo Hospitalario Universitario A Coruña, Spain

LeadR Profile

Roberto Barriales-Villa Complexo Hospitalario Universitario A Coruña Spain
1 441 ScienceLeadR Reputation 1441

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Public Health - Preventive Medicine - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Organizations

Source: Pubmed

Complexo Hospitalario Universitario A Coruña

Publications Synthesis

Source: Pubmed

Number : 400

Citations

Citations: 7 897 1st author: 31 Last author: 33 Unique author: 2

Main journals

EFSA J 155
Rev Esp Cardiol 31
Eur Heart J 29
Rev Esp Cardiol (Engl Ed) 25
J Am Coll Cardiol 24

Best Journals

Eur Heart J 20
Circulation 6
N Engl J Med 4

Breakdown by type

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Aficamten in symptomatic obstructive hypertrophic cardiomyopathy: the FOREST-HCM long-term study.
incidence, atrial fibrillation, cardiology, cardiomyopathy, hypertrophic, therapeutics, forests, cardiomyopathies		Eur Heart J Top journal20260
Assessment of the feed additive consisting of benzoic acid (4d210) (VevoVitall®) for weaned piglets, pigs for fattening, sows and minor porcine species for fattening and for reproduction for the renewal of its authorisation (DSM Nutritional Products Ltd).
skin, reproduction, safety, benzoic acid		EFSA J20260
Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase produced with Bacillus subtilisLMG S-15136 (Belfeed B MP/ML) (4a1606i) for all poultry species, suckling and weaned piglets, pigs for fattening, lactating sows and all minor porcine species other than reproductive animals for the renewal of its authorisation and the extension of its use to all Suidae (Puratos NV).
safety, poultry, bacillus, endo-1,4-beta xylanases, environment		EFSA J20260
Assessment of the feed additive consisting of coated granulated calcium iodate anhydrous for all animal species for the renewal of its authorisation (DOX-AL ITALIA SPA).
skin, safety, calcium		EFSA J20260
Safety and efficacy of a feed additive consisting of an essential oil derived from the flowering aerial parts of Mentha arvensis L. (cornmint oil) for use in all animal species (FEFANA asbl).
oils, volatile, safety, food, drinking, menthol		EFSA J20260

Clinical Studies 9

Source: ClinicalTrials

Synthesis

By phase:

Phase 3 5
Phase 2 2
N/A 1
Phase 2/Phase 3 1

By status:

Completed 7
Enrolling by invitation 1
Terminated 1

By type:

Interventional 8
Observational 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 9

Main Topics

Cardiovascular Diseases 9
Congenital, Hereditary, and Neonatal Diseases and Abnormalities 2

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Open label Extension Study to Evaluate the Long term Safety and Tolerability of Aficamten in Adults With HCM
NCT04848506 — safety, tablets, maintenance, cardiomyopathy, hypertrophic, research, therapeutics, forests, cardiomyopathies		Phase 2/Phase 3Enrolling by invitation2021

LeadR Networks

Main global connection map

Source: Pubmed Source: ClinicalTrials